Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ksv6178
    Junior Member
    • Nov 2024
    • 2

    #1

    Questions about ITS Region Amplicon Sequencing Quality Using Illumina MiSeq

    Hi, all.

    I'm analyzing fungal ITS amplicon data from gut samples. However, the data quality isn't very good—there's a noticeable drop in quality after around 240–250 bp.

    Additionally, when I researched other ITS amplicon data, I found some datasets with similarly low quality.

    So, I wanted to ask: If you’ve worked with ITS amplicon data, have you experienced issues with low-quality reads?

    Thank you!
    ​
  • ovon
    Junior Member
    • Feb 2016
    • 4

    #2
    I have, and that drop in quality after 250bp isn't unexpected in most amplicons. Using the dada2 ITS-specific protocol should be helpful, in that you can trim reads while accounting for length variability of the amplicon. I find that using this protocol and being more permissive about maxEE in dada2 - which the software is capable of handling safely - allows reasonable and even good read retention (average of >70% of reads retained) even in samples where read quality plots look a bit dubious

    Protocol is here: https://benjjneb.github.io/dada2/ITS_workflow.html

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2




      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
      Yesterday, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:51 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    71 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...